Eli Lilly Acquires Biotech Firm Dice

The pharmaceutical business isn’t all about weight-loss drugs. Drug-making giant Eli Lilly announced on Tuesday it agreed to buy Dice, a firm that specializes in making oral treatments for autoimmune diseases, for $2.4 billion, representing a 40% premium on Dice’s shares. Skin In The Game Eli…#elililly #dice #skiningameelililly #merck #argenx #rheumatoid #crohn #taltz #novonordisk #mounjaro
Source: Reuters: Health - Category: Consumer Health News Source Type: news